Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Silverman

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Novartis Foundation Symposium|February 24, 2001
Genetics of chronic obstructive pulmonary diseaseE K Silverman
Clinical Pharmacology and Therapeutics|December 6, 2012
Developing new drug treatments in the era of network medicineE K Silverman, J Loscalzo
Thorax|August 1, 2002
Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interactionA J Sandford, E K Silverman
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Genetics of asthma: conference summaryJ M Drazen, E K Silverman
Respiratory Research|November 1, 2001
The genetics of chronic obstructive pulmonary diseaseD A Lomas, E K Silverman
The Medical Clinics of North America|May 1, 1996
Risk factors for the development of chronic obstructive pulmonary diseaseE K Silverman, F E Speizer
Thorax|February 27, 2004
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema riskD L DeMeo, E K Silverman
American Journal of Respiratory Cell and Molecular Biology|June 6, 2000
Case-control association studies for the genetics of complex respiratory diseasesE K Silverman, L J Palmer
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1989
Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activityE J Campbell, E K Silverman, M A Campbell
The Pharmacogenomics Journal|March 23, 2002
Case-control association studies in pharmacogeneticsS T Weiss, E K Silverman, L J Palmer
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Novartis Foundation Symposium|February 24, 2001
Genetics of chronic obstructive pulmonary diseaseE K Silverman
Clinical Pharmacology and Therapeutics|December 6, 2012
Developing new drug treatments in the era of network medicineE K Silverman, J Loscalzo
Thorax|August 1, 2002
Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interactionA J Sandford, E K Silverman
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Genetics of asthma: conference summaryJ M Drazen, E K Silverman
Respiratory Research|November 1, 2001
The genetics of chronic obstructive pulmonary diseaseD A Lomas, E K Silverman
The Medical Clinics of North America|May 1, 1996
Risk factors for the development of chronic obstructive pulmonary diseaseE K Silverman, F E Speizer
Thorax|February 27, 2004
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema riskD L DeMeo, E K Silverman
American Journal of Respiratory Cell and Molecular Biology|June 6, 2000
Case-control association studies for the genetics of complex respiratory diseasesE K Silverman, L J Palmer
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1989
Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activityE J Campbell, E K Silverman, M A Campbell
The Pharmacogenomics Journal|March 23, 2002
Case-control association studies in pharmacogeneticsS T Weiss, E K Silverman, L J Palmer
Pageof 6